Loperamide induced cardiac arrhythmia successfully supported with veno-arterial ECMO (VA-ECMO), molecular adsorbent recirculating system (MARS) and continuous renal replacement therapy (CRRT)

Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists
Brandon Masi ParkerDaniel Haase

Abstract

Introduction: This case of Loperamide misuse had refractory ventricular arrhythmias and was successfully supported by VA ECMO. Loperamide is currently available without prescription and can be obtained in large quantities over the internet despite Food and Drug Administration (FDA) 2016 black box warning noting cardiac toxicity. This case illustrates the life-threatening toxicity of loperamide and suggests a supportive modality to provide clinical time while the drug is cleared endogenously or exogenously. Case report: A 36-year-old female was found minimally responsive. Vital signs and monitoring revealed wide complex bradycardia, undetectable blood pressure, hypothermia, bradypnea, and hypoglycemia. The rhythm degenerated to polymorphic ventricular tachycardia cardia refractory to multiple ACLS protocols. VA-ECMO was initiated with immediate stabilization. Subsequent history revealed massive consumption of loperamide taking 400-600 mg daily. Highest known loperamide and N-desmethyl-loperamide levels were 32 and 500 ng/ml respectively. Since loperamide and metabolites are known to be protein bound, molecular adsorbent recirculating system (MARS) was initiated for toxin clearance. Additionally, she developed acute renal failure...Continue Reading

References

May 1, 1980·Clinical Pharmacology and Therapeutics·A KoreyE M Sellers
Dec 1, 1980·Clinical Pharmacology and Therapeutics·J H JaffeJ Green
Jan 11, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·B StreelPh Hubert
Jan 20, 2006·Journal of Analytical Toxicology·Jason SklerovDavid Fowler
Jun 30, 2007·Clinical and Experimental Pharmacology & Physiology·Richard N Upton
Dec 4, 2012·Drug and Alcohol Dependence·Raminta DaniulaityteAmit Sheth
Mar 31, 2015·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·William EgglestonJeanna M Marraffa
May 4, 2015·BMJ Case Reports·Ryan MacDonaldJared Strote
Jun 9, 2015·The American Journal of Medicine·Evbu O EnakpeneJulia H Indik
Mar 30, 2016·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Rachel Sarah WightmanDaniel Lugassy
May 17, 2017·Annals of Emergency Medicine·Peter E Wu, David N Juurlink

❮ Previous
Next ❯

Citations

Aug 27, 2021·Clinical Practice and Cases in Emergency Medicine·David J BettingAngela F Jarman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.